This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collins, M. D.
Right arrow Articles by Facklam, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collins, M. D.
Right arrow Articles by Facklam, R. R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 1998, p. 2146-2148, Vol. 36, No. 7
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Facklamia ignava sp. nov., Isolated from Human Clinical Specimens

Matthew D. Collins,1 Paul A. Lawson,1 Rafael Monasterio,1 Enevold Falsen,2 Berit Sjöden,2 and Richard R. Facklam3,*

Department of Microbiology, BBSRC Institute of Food Research, Reading Laboratory, Reading, United Kingdom1; Culture Collection, Department of Clinical Bacteriology, University of Göteborg, Göteborg, Sweden2; and Centers for Disease Control and Prevention, Atlanta, Georgia3

Received 18 December 1997/Returned for modification 19 March 1998/Accepted 21 April 1998

Two strains of a hitherto-undescribed gram-positive, catalase-negative coccus isolated from human sources were characterized by phenotypic and molecular taxonomic methods. Comparative 16S rRNA gene sequencing studies demonstrated that the unknown strains are genealogically identical and constitute a new line close to, but distinct from, Facklamia hominis. The unknown bacterium was readily distinguished from F. hominis by biochemical tests and electrophoretic analysis of whole-cell proteins. On the basis of phylogenetic and phenotypic evidence, it is proposed that the unknown bacterium be classified as Facklamia ignava sp. nov. The type strain of Facklamia ignava is CCUG 37419.

* Corresponding author. Mailing address: Centers for Disease Control and Prevention, 1600 Clifton Rd., N.E., Atlanta, GA 30333. Phone: (404) 639-1379. Fax: (404) 639-3123. E-mail: RRF{at}CDC.GOV.

Journal of Clinical Microbiology, July 1998, p. 2146-2148, Vol. 36, No. 7
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • LaClaire, L., Facklam, R. (2000). Antimicrobial Susceptibilities and Clinical Sources of Facklamia Species. Antimicrob. Agents Chemother. 44: 2130-2132 [Abstract] [Full Text]  
  • LaClaire, L. L., Facklam, R. R. (2000). Comparison of Three Commercial Rapid Identification Systems for the Unusual Gram-Positive Cocci Dolosigranulum pigrum, Ignavigranum ruoffiae, and Facklamia Species. J. Clin. Microbiol. 38: 2037-2042 [Abstract] [Full Text]  
  • Lawson, P. A., Collins, M. D., Falsen, E., Sjöden, B., Facklam, R. R. (1999). Facklamia languida sp. nov., Isolated from Human Clinical Specimens. J. Clin. Microbiol. 37: 1161-1164 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»